Interactions between CYP1A1 polymorphisms and cigarette smoking are associated with the risk of hepatocellular carcinoma: Evidence from epidemiological studies

Molecular Biology Reports

Volumn 39, Issue 6, 2012, Pages 6641-6646

  Yu, Lei ^a   Sun, Lei ^a   Jiang, Yang Fang ^b   Lu, Bao Ling ^a   Sun, De Rong ^c   Zhu, Li Ying ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c Department of Infectious Disease   (China)

Author keywords

CYP1A1; Hepatocellular carcinoma; Meta analysis; Polymorphism

Indexed keywords

CYTOCHROME P450 1A1;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONTROLLED STUDY; CYTOCHROME P450 1A1 GENE; DISEASE ASSOCIATION; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONCOGENE; RISK ASSESSMENT; RISK FACTOR;

CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING;

EID: 84864286714     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-1469-3     Document Type: Article

References (30)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108 (Pubitemid 40372904)
2. Nerurkar PV, Okinaka L, Aoki C et al (2000) CYP1A1, GSTM1, and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals. Cancer Epidemiol Biomarkers Prev 9:1119-1122
3. Masson LF, Sharp L, Cotton SC, Little J (2005) Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol 161:901-915 (Pubitemid 40656412)
4. Kisselev P, Schunck WH, Roots I, Schwarz D (2005) Association of CYP1A1 polymorphisms with differential metabolic activation of 17betaestradiol and estrone. Cancer Res 65:2972-2978 (Pubitemid 40490103)
5. Yu MW, Chiu YH, Yang SY et al (1999) Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. Br J Cancer 80:598-603
6. Zhu WC, Chen Q, Luo CL, Chu XW, Wu M (2001) Relationships between polymorphisms of CYP1A1 and GSTM1 with genetic susceptibility of hepatocellar carcinoma. Chin J Cancer Prev Treat 8:572-574
7. Silvestri L, Sonzogni L, De Silvestri A et al (2003) CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. Int J Cancer 104:310-317 (Pubitemid 36249813)
8. Cao YY (2004) Study on genetic and environmental factors in hepatocellar carcinoma in Luoyang, China. Master's Thesis of Fudan University, pp 1-78
9. Wu XH, Yang XY, Duan W, Wang B, Yang SJ (2007) The relationship between genetic polymorphism of cytochrome p450 and susceptibility to hepatocellular carcinoma. Acta Acad Med CPAPF 16(47-48):62
10. Yuan X, Zhou G, Zhai Y et al (2008) Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma. Cancer Epidemiol Bio-markers Prev 17:3621-3627
11. Li R, Shugart YY, Zhou W et al (2009) Common genetic variations of the cytochrome P450 1A1 gene and risk of hepatocellular carcinoma in a Chinese population. Eur J Cancer 45:1239-1247
12. Yin PH, Lee HC, Chau GY et al (2004) Polymorphisms of estrogen-metabolizing genes and risk of hepatocellular carcinoma in Taiwan females. Cancer Lett 212:195-201
13. Imaizumi T, Higaki Y, Hara M et al (2009) Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population. Carcinogenesis 30:1729-1734
14. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188 (Pubitemid 17189972)
15. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
16. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
17. Egger M, Davey Smith G, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629-634 (Pubitemid 27387172)
18. Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ (1999) A p53 genetic polymorphism as a modulator of hepato-cellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 29:697-702
19. Han XM, Zhou HH (2000) Polymorphism of CYP450 and cancer susceptibility. Acta Pharmacol Sin 21:673-679
20. Zhuo W, Wang Y, Zhuo X et al (2009) CYP1A1 and GSTM1 polymorphisms and oral cancer risk: association studies via evidence-based meta-analyses. Cancer Invest 27:86-95
21. Zheng Y, Wang JJ, Sun L, Li HL (2011) Association between CYP1A1 polymorphism and colorectal cancer risk: a meta-analysis. Mol Biol Rep. doi:10.1007/s11033-011-1126-2
22. Chen Z, Li Z, Niu X et al (2011) The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies. Mutagenesis 26:437-446
23. Sergentanis TN, Economopoulos KP (2010) Four polymorphisms in cytochrome p450 1a1 (CYP1A1) gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 122:459-469
24. Shaik AP, Jamil K, Das P (2009) CYP1A1 polymorphisms and risk of prostate cancer: a meta-analysis. Urol J 6:78-86
25. Srivastava K, Srivastava A, Sharma KL, Mittal B (2011) Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res 728:67-79
26. Sergentanis TN, Economopoulos KP, Choussein S, Vlahos NF (2011) Cytochrome p450 1a1 gene polymorphisms and endo-metrial cancer risk: a meta-analysis. Int J Gynecol Cancer 21: 323-331
27. Hiyama T, Yoshihara M, Tanaka S, Chayama K (2008) Genetic polymorphisms and head and neck cancer risk (Review). Int J Oncol 32:945-973
28. Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M et al (2011) Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst 103:1686-1695
29. Koh WP, Robien K, Wang R, Govindarajan S, Yuan JM, Yu MC (2011) Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study. Br J Cancer 105:1430-1435
30. Chuang SC, Lee YC, Hashibe M et al (2010) Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Bio-markers Prev 19:1261-1268